Members |
acceptabilityId |
166 |
Preferred (foundation metadata concept) |
166 (qualifier value) |
Preferred (foundation metadata concept) |
166-Yb |
Acceptable (foundation metadata concept) |
166.667 |
Preferred (foundation metadata concept) |
166.667 (qualifier value) |
Preferred (foundation metadata concept) |
16600 |
Preferred (foundation metadata concept) |
16600 (qualifier value) |
Preferred (foundation metadata concept) |
16667 |
Preferred (foundation metadata concept) |
16667 (qualifier value) |
Preferred (foundation metadata concept) |
1667 |
Preferred (foundation metadata concept) |
1667 (qualifier value) |
Preferred (foundation metadata concept) |
167 |
Preferred (foundation metadata concept) |
167 (qualifier value) |
Preferred (foundation metadata concept) |
168 |
Preferred (foundation metadata concept) |
168 (qualifier value) |
Preferred (foundation metadata concept) |
1680 |
Preferred (foundation metadata concept) |
1680 (qualifier value) |
Preferred (foundation metadata concept) |
16800 |
Preferred (foundation metadata concept) |
16800 (qualifier value) |
Preferred (foundation metadata concept) |
169-Er |
Acceptable (foundation metadata concept) |
169-Hf |
Acceptable (foundation metadata concept) |
169-Yb |
Acceptable (foundation metadata concept) |
16G |
Preferred (foundation metadata concept) |
16G (qualifier value) |
Preferred (foundation metadata concept) |
16PF - Personality factor questionnaire |
Acceptable (foundation metadata concept) |
16p partial trisomy syndrome |
Preferred (foundation metadata concept) |
16p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
16p11.2 deletion syndrome |
Acceptable (foundation metadata concept) |
16p11.2p12.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
16p11.2p12.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16p11.2p12.2 microduplication syndrome |
Preferred (foundation metadata concept) |
16p11.2p12.2 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
16p12.1p12.3 triplication syndrome |
Preferred (foundation metadata concept) |
16p12.1p12.3 triplication syndrome (disorder) |
Preferred (foundation metadata concept) |
16p12.2 microdeletion |
Acceptable (foundation metadata concept) |
16p12.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
16p12.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16p13.11 microdeletion syndrome |
Preferred (foundation metadata concept) |
16p13.11 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16p13.11 microduplication syndrome |
Preferred (foundation metadata concept) |
16p13.11 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
16p13.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
16p13.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16p13.3 microduplication syndrome |
Preferred (foundation metadata concept) |
16p13.3 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
16q partial monosomy syndrome |
Preferred (foundation metadata concept) |
16q partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
16q partial trisomy syndrome |
Preferred (foundation metadata concept) |
16q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
16q24.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
16q24.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16q24.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
16q24.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
16x/day |
Acceptable (foundation metadata concept) |
17 |
Acceptable (foundation metadata concept) |
17 |
Preferred (foundation metadata concept) |
17 (qualifier value) |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement (procedure) |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement, amniotic fluid |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement, amniotic fluid (procedure) |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement, serum |
Preferred (foundation metadata concept) |
17 Hydroxyprogesterone measurement, serum (procedure) |
Preferred (foundation metadata concept) |
17 OHP - 17-hydroxyprogesterone |
Acceptable (foundation metadata concept) |
17 alpha-Hydroxylase deficiency |
Acceptable (foundation metadata concept) |
17 alpha-Hydroxyprogesterone aldolase deficiency |
Preferred (foundation metadata concept) |
17 alpha-Hydroxyprogesterone aldolase deficiency (disorder) |
Preferred (foundation metadata concept) |
17 alpha-hydroxyprogesterone |
Acceptable (foundation metadata concept) |
17 alpha-hydroxyprogesterone |
Preferred (foundation metadata concept) |
17 alpha-hydroxyprogesterone (substance) |
Preferred (foundation metadata concept) |
17 beta-estradiol |
Preferred (foundation metadata concept) |
17 beta-estradiol (substance) |
Preferred (foundation metadata concept) |
17 beta-estradiol preparation |
Preferred (foundation metadata concept) |
17 beta-estradiol preparation (product) |
Preferred (foundation metadata concept) |
17 beta-hydroxysteroid dehydrogenase |
Acceptable (foundation metadata concept) |
17,18,21-trihydroxypregn-4-ene-3,11,20-trione |
Acceptable (foundation metadata concept) |
17,21-dihydroxypregnenolone |
Preferred (foundation metadata concept) |
17,21-dihydroxypregnenolone (substance) |
Preferred (foundation metadata concept) |
17,21-hydroxyprogesterone |
Acceptable (foundation metadata concept) |
17-Beta-estriol |
Preferred (foundation metadata concept) |
17-Beta-estriol (substance) |
Preferred (foundation metadata concept) |
17-Hydroxycorticosteroid |
Preferred (foundation metadata concept) |
17-Hydroxycorticosteroid (substance) |
Preferred (foundation metadata concept) |
17-Hydroxyketosteroids measurement |
Preferred (foundation metadata concept) |
17-Hydroxyketosteroids measurement (procedure) |
Preferred (foundation metadata concept) |
17-Hydroxypregnenolone measurement |
Preferred (foundation metadata concept) |
17-Hydroxypregnenolone measurement (procedure) |
Preferred (foundation metadata concept) |
17-KGS measurement |
Acceptable (foundation metadata concept) |
17-KS measurement |
Acceptable (foundation metadata concept) |
17-KS measurement, fractionation |
Acceptable (foundation metadata concept) |
17-KSR deficiency |
Acceptable (foundation metadata concept) |
17-Ketogenic steroid |
Preferred (foundation metadata concept) |
17-Ketogenic steroid (substance) |
Preferred (foundation metadata concept) |
17-Ketogenic steroids measurement |
Preferred (foundation metadata concept) |
17-Ketogenic steroids measurement (procedure) |
Preferred (foundation metadata concept) |
17-Ketosteroid reductase deficiency |
Acceptable (foundation metadata concept) |
17-Ketosteroids |
Acceptable (foundation metadata concept) |
17-Ketosteroids measurement |
Preferred (foundation metadata concept) |
17-Ketosteroids measurement (procedure) |
Preferred (foundation metadata concept) |
17-Ketosteroids measurement, fractionation, urine |
Preferred (foundation metadata concept) |
17-Ketosteroids measurement, fractionation, urine (procedure) |
Preferred (foundation metadata concept) |